BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Sastravi

Presentation	Product	Chemical substance	Chapter	Items dispensed
Sastravi 150mg/37.5mg/200mg tablets 0409010X0BCAEAC	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	1,565
Sastravi 125mg/31.25mg/200mg tablets 0409010X0BCAAAF	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	1,434
Sastravi 100mg/25mg/200mg tablets (Accord Healthcare Ltd) 0409010X0BCAHAB	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	1,133
Sastravi 200mg/50mg/200mg tablets 0409010X0BCAGAD	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	827
Sastravi 175mg/43.75mg/200mg tablets (Accord Healthcare Ltd) 0409010X0BCAJAG	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	498
Sastravi 75mg/18.75mg/200mg tablets 0409010X0BCACAE	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	410
Sastravi 100mg/25mg/200mg tablets (Actavis UK Ltd) 0409010X0BCADAB	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	366
Sastravi 50mg/12.5mg/200mg tablets (Accord Healthcare Ltd) 0409010X0BCAIAA	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	199
Sastravi 175mg/43.75mg/200mg tablets (Actavis UK Ltd) 0409010X0BCAFAG	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	64
Sastravi 50mg/12.5mg/200mg tablets (Actavis UK Ltd) 0409010X0BCABAA	Sastravi	Levodopa/carbidopa/entacapone	Central Nervous System	46

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.